Abstract:Asian American (24 million people) and Native Hawaiian and other Pacific Islander (1.7 million people) individuals represent 8% of the US population. 1 Cancer is the leading cause of death among many Asian American groups (Chinese, Filipino, Vietnamese, and Korean) and is the second leading cause of death among Native Hawaiian, Indian, and Japanese American people. 1 A growing body of research has focused on cancer among these very diverse groups, elucidating their unique and dynamic cancer risk factors, epidemiology, and access to care. 2 ,3 Zhu et al 4 evaluated cancer-specific mortality (CSM) rates for Asian American, Native Hawaiian, and other Pacific Islander individuals from 1999 to 2020 using the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research database. They found that for these groups in aggregate, CSM rates decreased over the past 2 decades and that decreases were greater among men than among women. The CSM rates among women increased for cancers of the uterus and the brain and central nervous system but decreased for other cancer sites. Upon analysis by age, women aged 65 to 74 years experienced the greatest increase in mortality from uterine cancer. Among men, CSM rates decreased overall, with the greatest decreases in cancers of the stomach and lung. Decreases in CSM were greatest in cancers of the liver and lung among men aged 35 to 44 years; however, colorectal cancer mortality increased among men aged 45 to 54 years, and after a decrease from 2002 to 2012, prostate cancer increased among men aged 64 to 74 years (from 2012 to 2020). The authors found increased mortality for pancreatic cancer in the Midwest and for uterine cancer and liver cancer across all US census regions. The study by Zhu et al 4 highlights the need to further study and address the cancer burden among these rapidly growing populations. 1 Their work is nationally representative and may inform cancer policy. Their findings illustrate how cancer mortality has changed over time, reflecting changes in risk factors, screening rates, and timely and equitable access to quality cancer care. 2 -4 The study is limited by the aggregation of diverse Asian American and Pacific Islander groups, who exhibit some of the widest disparities in social determinants of health across census groups, 1 -3 a limitation inherent in the dataset that masks heterogeneity in cancer mortality. 1 -3 Heterogeneity in cancer mortality is notable. The age-adjusted mortality rate for all cancer subsites is 142 per 100 000 for Native Hawaiian and Pacific Islander patients, 91 per 100 000 for Asian American patients, and 153 per 100 000 for White patients. 1 For uterine cancer, the age-adjusted mortality rate is 16 per 100 000 for Native Hawaiian and Pacific Islander patients compared with 5 per 100 000 for White patients and 3 per 100 000 for Asian American patients. 1 For breast cancer, 5-year relative survival is 94% for Japanese American and 93% for White and Chinese patients compared with 72% for Tongan, 73% for Chamorro and Guamanian, and 74% for Samoan patients. 1 For cancers of the lung and bronchus, 5-year relative survival is 37% for Thai, 36% for Chinese, 35% for Pakistani, and 29% for Indian patients compared with 25% for White, 18% for Samoan, 15% for Tongan, and 11% for Laotian patients. 1 Such heterogeneity in mortality may reflect differences across the continuum of disease leading up to mortality estimates. 2 Considering the current study and in the context of such heterogeneity, what are the next steps? First, further disaggregated research is needed to examine the drivers of these temporal changes. Although CSM has decreased overall for Asian American, Native Hawaiian, and Pacific Islander patients, decreases in lung CSM may be driven by relatively better survival among Chinese and Indian patients (and perhaps to a lesser extent by the smaller Thai and Pakistani populations) but may not reflect the substantially lower survival among several Pacific Islander and Southeast Asian (eg, Laotian) groups. 1 Increases in uterine CSM may reflect the burden of disease among Native Hawaiian and Pacific Islander individuals, among whom focused studies and interventions are needed. 1 ,3 Further research could explore how cancer risk compares between immigrants and people in their countries of origin and how cancer risk changes across generations of immigrants. 5 Parallels between immigrants and their countries of origin may inform targeted diagnostics, as exemplified by the high rate of gastric cancer among Korean American individuals reflecting epidemiology in Korea. 1 ,5 Such work may also elucidate how risk changes in th -Abstract Truncated-

Assessing racial, ethnic, and nativity disparities in US cancer mortality using a new integrated platform

Disparities in cancer mortality outcomes among adult immigrants in the United States.

Cancer Mortality among Hispanic groups in the US, by birthplace (2003-2017)

Abstract 2223: Cancer risk factors and nativity: Lifestyle and sociodemographic disparities among us-born and non-us-born residents and by length of residence in the US

Differences in modifiable cancer risk behaviors by nativity (US-born v. Non-US-born) and length of time in the US

Racial Disparities in Young-Onset Patients with Colorectal, Breast and Testicular Cancer

Variation in Cancer Incidence Rates Among Non-Hispanic Black Individuals Disaggregated by Nativity and Birthplace, 2005-2017: A Population-Based Cancer Registry Analysis

Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950–2014: Over Six Decades of Changing Patterns and Widening Inequalities

A bird's-eye view of disparity from public historic cancer mortality data in the US: Advocacy for gastrointestinal cancers and for inter-agency data harmonization.

The Fluctuating Incidence, Improved Survival of Patients with Breast Cancer, and Disparities by Age, Race, and Socioeconomic Status by Decade, 1981-2010

Disaggregated Cancer Research and Intervention for Asian American and Pacific Islander People

Abstract A071: County-level racial and ethnic diversity index and cancer mortality in the U.S.

Abstract A104: EpiTracker Cancer: A new webtool to visualize disparities in cancer death rates across demographics and county-level characteristics

Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California

Nasopharyngeal cancer mortality in disaggregated Asian and non‐Asian Americans

Demographic disparities in lung cancer mortality and trends in the United States between 1999 and 2020: A population-based CDC database analysis.

Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities

Lung cancer mortality trends and disparities: A cross-sectional analysis 1999-2020

Disparities in Cancer Mortality among Disaggregated Asian American Subpopulations, 2018–2021

Abstract A025: Trends in liver cancer mortality by sex, race, and ethnicity in California from 2000-2019

Abstract C039: Nativity and breast cancer outcomes by breast cancer subtype in the ENCLAVE Study